Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See
full details
.
I Agree
×
Join today and have your say! It’s FREE!
Join Now
Sign In
Become a member today, It's free!
We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.
Join Today
or
Sign in with existing account
Privacy Policy
|
Disclaimer
Sign In
Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Remember me
Forgot Password?
Sign In
or
Sign Up
Privacy Policy
|
Disclaimer
Please Try Again
{{ error }}
Send my password
Submit
Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.
Become a member today, It's free!
We will not release or resell your information to third parties without your permission.
Linking with Facebook:
Stockhouse membership requires an email address which must be shared by Facebook.
By default, joining or signing in using your Facebook account will work and the email address will be shared by Facebook automatically.
If you change your Facebook permissions to restrict Stockhouse from receiving your email while joining or signing in to Stockhouse then it will fail.
Please do not modify the permission settings during sign-in.
Sign in with Facebook
Return to Signup Options
Home
Community
Bullboards
Blogs
Groups
Messages
Markets
Stocks
TSX
TSXV
CSE
Cboe Canada
NASDAQ
NYSE
NYSE American
Cryptocurrency
Currencies
Market Movers
Bonds
News
Featured News
Trending News
Canadian Press Releases
US Press Releases
Video
Editorial
Thematic Insights
Independent Reports
Interviews
Buzz on the Bullboards
Portfolio
Watchlist
Portfolio
Showcase Companies
DealRoom
Quote
|
Bullboard
|
News
|
Opinion
|
Profile
|
Peers
|
Filings
|
Financials
|
Options
|
Price History
|
Ratios
|
Ownership
|
Insiders
|
Valuation
Bullboard - Stock Discussion Forum
Antibe Therapeutics Inc(Pre-Merger)
ATBPF
Healthcare
Antibe Therapeutics Inc. is a clinical-stage biotechnology company. The Company is leveraging its hydrogen sulfide (H2S) platform to develop therapies to target inflammation arising from a range of medical conditions. The Company’s pipeline includes assets that seek to overcome the gastrointestinal ulcers and bleeding associated with nonsteroidal anti-inflammatory drugs (NSAIDs). Its lead drug,...
otenaproxesul, is in clinical development as an alternative to opioids and NSAIDs for acute pain. Its second pipeline drug, ATB-352, is being developed for a specialized pain indication. The Company also focuses on inflammatory bowel disease (IBD). Otenaproxesul combines a moiety that releases hydrogen sulfide with naproxen, a non-steroidal, anti-inflammatory drug. ATB-352 is an H2S-releasing derivative of ketoprofen, a potent NSAID commonly prescribed for acute pain. Its IBD candidates are being designed to maintain the efficacy, safety, and pharmacokinetic properties of ATB-429.
see more
Join the community and start posting on the bullboards today. It's free.
You are already a member! Please enter your password to sign in.
Remember me
Forgot password?
Back
Submit
By providing my email, I consent to receiving messages from Stockhouse.
Create a portfolio watchlist today. It's free.
You are already a member! Please enter your password to sign in.
Remember me
Forgot password?
Back
Submit
By providing my email, I consent to receiving messages from Stockhouse.
Add To Watchlist
Bullboard (GREY:ATBPF)
New Post
View:
Posts & Comments
Threaded Posts
Prev
...
21
22
23
24
25
26
27
28
29
30
31
32
33
34
35
36
37
38
39
40
...
Next
(1093)
•••
Duster340
X
View Profile
View Bullboard History
Post by
Duster340
on Jan 16, 2024 2:55pm
Are we moving higher
before the thursday info drop? maybe some last minute buying before the close tomorrow or thursday morning? funny how the stock is now just high enough for the warrants to be exercised, i am sure most
...more
(1093)
•••
Duster340
X
View Profile
View Bullboard History
Post by
Duster340
on Jan 16, 2024 12:23pm
Actually (pre merger)
might mean before the merger of the 65 million new shares that will be issued and added to the existing shares.
(1093)
•••
Duster340
X
View Profile
View Bullboard History
Post by
Duster340
on Jan 16, 2024 10:28am
If there is a merger
my guess it is with nuance pharma. deep pockets? the plot thickens. lol About Nuance Pharma Nuance is a Shanghai-based late clinical-stage biopharmaceutical company focused on
...more
(1093)
•••
Duster340
X
View Profile
View Bullboard History
Post by
Duster340
on Jan 16, 2024 10:06am
RE: Why
that is new. i just now notice it, no announcement of a merge yet?
(22)
•••
Forestview
X
View Profile
View Bullboard History
Post by
Forestview
on Jan 16, 2024 9:56am
Why?
Why does the title of this bullboard say Antibe Therapeutics Inc (Pre Merger)? What's the signficance of Pre Merger??
(1093)
•••
Duster340
X
View Profile
View Bullboard History
Post by
Duster340
on Jan 16, 2024 9:36am
RE:RE: Upcoming Discussion
Dan must have an ace up his sleeve for thursday to get the stock price comfortably above the $1 mark. the usual blah blah blah combined with the dillution of shares will move the stock back under $1
...more
(128)
•••
MrMugsy
X
View Profile
View Bullboard History
Comment by
MrMugsy
on Jan 16, 2024 9:11am
RE:RE:Upcoming Discussion ...
Regardless of easier or harder - both acute and chronic are huge markets on their own. Also, acute is a short window for painkiller usage which makes OTENA a perfect candidate. Chronic is
...more
(379)
•••
Benedictus
X
View Profile
View Bullboard History
Comment by
Benedictus
on Jan 15, 2024 11:48pm
RE:Upcoming Discussion ...
I recall Dan saying a long while back that partnering opportunities for acute would be easier than chronic. Do you agree with that or is that just Dan speak in the same vein as his AME debacle "
...more
(1093)
•••
Duster340
X
View Profile
View Bullboard History
Post by
Duster340
on Jan 15, 2024 10:59am
Insider Buying
no one selling their vested rsu's but instead trading for common shares. although not a huge amount Filing Date Transaction Date Insider Name
...more
(128)
•••
MrMugsy
X
View Profile
View Bullboard History
Post by
MrMugsy
on Jan 14, 2024 12:27pm
Upcoming Discussion ...
January 18th ... Learn about the benefits of otenaproxesul’s new formulation, dive into Antibe’s recently released data and Phase II planning, and explore the future of pain management. ----------
...more
(128)
•••
MrMugsy
X
View Profile
View Bullboard History
Comment by
MrMugsy
on Jan 14, 2024 10:34am
RE:RE:RE:RE:After today🤞
It is not in the right time for Institutional investors - but - that could change quickly as risk is reduced and success is had. Also, it isn't the institutional investors who would
...more
(12)
•••
Jefnan1
X
View Profile
View Bullboard History
Comment by
Jefnan1
on Jan 13, 2024 5:55pm
RE:RE:RE:After today🤞
This company is too small for any institution to have any interest unless they decide to buy the whole thing
(128)
•••
MrMugsy
X
View Profile
View Bullboard History
Comment by
MrMugsy
on Jan 12, 2024 8:34pm
RE:After today🤞
If anything - January 18th is about the power of OTENA. Some may be obvious - the rest will require some "reading between the lines." As always.
(128)
•••
MrMugsy
X
View Profile
View Bullboard History
Comment by
MrMugsy
on Jan 12, 2024 8:31pm
RE:RE:After today🤞
True - agreed !!! These are retail investors ... and I'd bet many are just coming back now (past owners of ATE). Important institutional buying will be closely related to a US market move.
...more
(55)
•••
Harper75
X
View Profile
View Bullboard History
Comment by
Harper75
on Jan 12, 2024 12:56pm
RE:After today🤞
IMO we are a ways off from any Ititutional buying...
Prev
...
21
22
23
24
25
26
27
28
29
30
31
32
33
34
35
36
37
38
39
40
...
Next
Thank You
Your Report has been submitted.
Report Abusive Content
×
Close
Sign up to get access
You are already a member! Please enter your password to sign in.
Remember me
Forgot password?
Back
Submit
By providing my email, I consent to receiving messages from Stockhouse.
The Market Update
{{currentVideo.title}}
{{currentVideo.relativeTime}}
< Previous bulletin
Next bulletin >
A daily snapshot of everything
from market open to close.
{{currentVideo.companyName}}
{{currentVideo.intervieweeName}}
{{currentVideo.intervieweeTitle}}
{{currentVideo.headline}}
{{currentVideo.link1Text}}
{{currentVideo.link2Text}}
< Previous
{{moreVideoText}}
Next >